Search results
Investors Take AbbVie To The Woodshed. But Its Woes Are 'Unfounded.'Investors Take AbbVie To The...
Investor's Business Daily· 3 days agoOn Friday, AbbVie beat first-quarter expectations, largely on the back of its immunology franchise....
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition
Investing.com· 4 days agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...
AbbVie (ABBV) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 6 days agoImage source: The Motley Fool. AbbVie (NYSE: ABBV) Q1 2024 Earnings Call Apr 26, 2024, 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
AbbVie Raises Earnings Guidance Even as Humira Sales Continue to Drop
Barrons.com· 6 days agoAbbVie reports better-than-expected adjusted earnings in the first quarter.Read the full article
AbbVie earnings beat by $0.04, revenue topped estimates
Investing.com· 7 days agoAbbVie earnings beat by $0.04, revenue topped estimates
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Zacks· 2 days agoFree Report) has recently been on Zacks.com's list of the most searched stocks. The Zacks Large Cap Pharmaceuticals industry, to which AbbVie belongs, has lost 1.9% over this ...
Why AbbVie Stock Stumbled Today Despite the Earnings Beat
Motley Fool via Yahoo Finance· 6 days agoBy almost any measure, AbbVie (NYSE: ABBV) shares should have risen Friday. The pharmaceutical giant...
New Cancer 'Missile' Drugs May Be More Effective Than Traditional Chemotherapy
Verywell Health via Yahoo News· 3 hours agoThe treatment, Elahere (mirvetuximab soravtansine), is for patients with late-stage disease who have...
AbbVie (NYSE:ABBV) Shares Down 0.5% After Analyst Downgrade
ETF DAILY NEWS· 2 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shares fell 0.5% on Monday after Barclays lowered their price target on the stock from $195.00 to $187.00. AbbVie
AbbVie Inc: An Exploration into Its Intrinsic Value
GuruFocus.com via Yahoo Finance· 2 days agoIn this article, we will take a look into AbbVie Inc's (NYSE:ABBV) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value....